As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Kimera
Experienced Member
2 hours ago
Free US stock earnings trajectory analysis and revision trends to understand fundamental momentum. We track how analyst estimates have been changing over time to gauge improving or deteriorating expectations.
π 145
Reply
2
Kezra
Power User
5 hours ago
Who else is feeling this right now?
π 57
Reply
3
Kashara
Trusted Reader
1 day ago
Clear, concise, and actionable β very helpful.
π 187
Reply
4
Ihlani
Registered User
1 day ago
Too late to take advantage now. π
π 75
Reply
5
Salym
Engaged Reader
2 days ago
Free US stock comparative valuation tools and peer analysis to identify mispriced securities and find value opportunities in the market. We help you understand relative value across different metrics and time periods for better investment decisions. Our platform offers peer comparisons, relative valuation, and spread analysis for comprehensive valuation coverage. Find mispriced stocks with our comprehensive valuation tools and expert analysis for smarter investment selection.
π 59
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.